BINHUI BIOPHARMA files for H-share listing and "full circulation" with CSRC filing, up to 38.10 million shares to be issued

NewTimeSpace News: Wuhan Binhui Biopharmaceutical Co., Ltd. announced that its filing materials for overseas listing and issuance and the "full circulation" of domestic unlisted shares have been received by the China Securities Regulatory Commission (CSRC), and the Company has received the filing notice. Pursuant to the Securities Law of the People's Republic of China, the Trial Administrative Measures for Overseas Securities Offering and Listing by Domestic Companies, the Business Guidelines for H-Share Companies Applying for "Full Circulation" of Domestic Unlisted Shares and other regulations, the filing matters include: the Company plans to issue no more than 38,102,600 overseas listed ordinary shares for listing on the Hong Kong Stock Exchange; and 54 shareholders of the Company plan to convert an aggregate of 150,933,379 domestic unlisted shares held by them into overseas listed shares for listing and circulation on the Hong Kong Stock Exchange.

According to the filing notice: from the date of issuance of the filing notice until the completion of this overseas issuance and listing, if any major matter occurs, the Company shall report through the CSRC filing management information system in accordance with the relevant provisions on overseas issuance and listing of domestic companies; within 15 working days after completing its overseas listing and issuance, the Company shall report the status of the listing and issuance through the filing management information system; and if the Company intends to continue and has not completed the overseas listing and issuance and share conversion within 12 months from the date of the filing notice, it shall update the filing materials.

The filing notice only confirms the filing information of the Company's overseas listing and issuance and "full circulation", and does not constitute a substantive judgement by the CSRC on the investment value of the Company's securities or investors' returns, nor a guarantee by the CSRC of the authenticity, accuracy or completeness of the Company's filing materials.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.